Orbimed Capital LLC
SEC-identified person · CIK 1157524 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Prelude Therapeutics Inc PRLD | Director | filed 2020 - 2026 |
| Silverback Therapeutics, Inc. SPRY | Director | filed 2020 - 2024 |
| Kinnate Biopharma Inc. KNTE | Director | filed 2020 - 2024 |
| Sierra Oncology, Inc. SRRA | Director | filed 2019 - 2022 |
| Arcutis Biotherapeutics, Inc. ARQT | Director | filed 2020 - 2022 |
| PMV Pharmaceuticals, Inc. PMVP | Director | filed 2020 - 2022 |
| Repare Therapeutics Inc. RPTX | Director | filed 2020 - 2021 |
| Imara Inc. IMRA | Director | filed 2021 - 2021 |
| Decibel Therapeutics, Inc. [DBTX] | Director | filed 2021 - 2021 |
| Fusion Pharmaceuticals Inc. FUSN | Director | filed 2020 - 2020 |
| Alector, Inc. ALEC | Director | filed 2019 - 2020 |
| Chemocentryx, Inc. CCXI | Officer | filed 2012 - 2012 |
| Cryocor INC CRYO | Officer | filed 2007 - 2007 |
| Given Imaging LTD GIVN | Director | filed 2006 - 2006 |
| DOV Pharmaceutical INC DVOP | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.